Huntington Bancshares
HBAN
$17.16
-1.15%
Huntington Bancshares Inc is a regional US bank offering a full suite of consumer deposit and lending services, along with commercial services including payments, investment management, capital markets, equipment financing, and treasury management. As a mid-tier regional bank with over $285 billion in assets, it competes by focusing on relationship banking and its Midwest footprint. The current investor narrative centers on the bank's ability to sustain net interest income growth amid a shifting rate environment, with recent quarterly results showing strong revenue expansion and improving profitability, though the stock has underperformed the broader market over the past year.…
HBAN
Huntington Bancshares
$17.16
HBAN 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Huntington Bancshares's 12-month outlook, with a consensus price target around $20.34 and implied upside of +18.6% versus the current price.
Average Target
$20.34
0 analysts
Implied Upside
+18.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$18 - $23
Analyst target range
The stock is covered by 18 analysts, with a consensus recommendation of 'Buy' (mean recommendation 1.68 on a 1-5 scale where 1 is Strong Buy). The average target price is $20.39, implying 17.5% upside from the current price of $17.36. The distribution shows 10 Buy/Overweight ratings, 7 Hold, and 1 Sell, indicating a generally bullish sentiment. The target range spans from $18.00 (low) to $22.50 (high). The high target of $22.50 assumes continued revenue growth and margin expansion, while the low target of $18.00 reflects concerns about net interest margin compression or economic slowdown. Recent ratings actions include Jefferies downgrading from Buy to Hold on July 6, 2026, while UBS, JP Morgan, and Evercore ISI have maintained positive ratings. The spread between low and high targets ($4.50) is moderate, suggesting reasonable uncertainty but not extreme divergence in views.
Bulls vs Bears: HBAN Investment Factors
Huntington Bancshares presents a mixed picture: strong revenue acceleration and attractive valuation are countered by market underperformance and margin pressures. The bull case rests on the stock's discounted valuation (12.3x trailing P/E vs. 15.0x industry) and robust revenue growth of 26.3% YoY, which could drive earnings expansion and multiple re-rating. The bear case highlights net margin compression from 17.7% to 13.9%, a low ROE of 9.1%, and the stock's persistent underperformance relative to the S&P 500. The single most important tension is whether the bank can sustain its revenue growth trajectory while stabilizing margins; if net margins recover, the stock could see significant upside, but further compression would validate the market's skepticism.
Bullish
- Strong Revenue Growth: Revenue grew 26.3% YoY in Q1 2026 to $3.768 billion, accelerating from 2.0% growth in Q2 2025, driven by higher net interest income and fee income.
- Attractive Valuation Discount: Trailing P/E of 12.3x and forward P/E of 9.2x represent an 18% discount to the industry average of 15.0x, with a PEG ratio of 0.90 suggesting undervaluation relative to growth.
- Improving Profitability Trends: Gross margin improved to 64.1% in Q1 2026 from 57.4% in Q3 2024, while operating margin of 17.0% remains healthy, indicating better cost management and net interest margin expansion.
- Strong Free Cash Flow Generation: TTM free cash flow of $2.206 billion provides ample coverage for dividends and investments, with a payout ratio of 46% and a dividend yield of 4.0%.
Bearish
- Underperformance vs. Market: The stock's 1-year return of +4.33% significantly lags the S&P 500's +16.47%, with negative relative strength over 1-year (-12.1%) and YTD (-9.0%).
- Net Margin Compression: Net margin declined to 13.9% in Q1 2026 from 17.7% in Q1 2025, despite revenue growth, indicating rising costs or provisions that could pressure earnings.
- Moderate Return on Equity: ROE of 9.1% is below many regional bank peers, suggesting less efficient capital utilization and potentially limiting valuation multiple expansion.
- Sensitivity to Interest Rate Changes: As a regional bank, net interest income is highly sensitive to Fed rate decisions; a declining rate environment could compress margins, while higher rates may slow loan demand.
HBAN Technical Analysis
The stock is in a recovery phase from a downtrend, with a 1-year price change of +4.33%, significantly lagging the S&P 500's +16.47% gain. The current price of $17.36 sits at 70.7% of its 52-week range ($14.89 - $19.46), indicating it has bounced off lows but remains well below the highs, suggesting a cautious recovery rather than a full-blown uptrend. Over the past 3 months, the stock has gained 5.85%, outperforming the S&P 500's 3.50% return, while the 1-month change of -1.25% contrasts with the S&P 500's +0.78%, showing short-term weakness. This divergence between the positive 3-month trend and negative 1-month trend could signal a temporary pullback within a broader recovery, or a loss of momentum. The 52-week low of $14.89 provides key support, while the 52-week high of $19.46 is the immediate resistance. A breakout above $19.46 would signal a resumption of the uptrend, while a breakdown below $14.89 would indicate renewed downside. With a beta of 0.95, the stock is slightly less volatile than the market, meaning it may offer relative stability but also less upside in strong market rallies.
Beta
0.95
0.95x market volatility
Max Drawdown
-22.1%
Largest decline past year
52-Week Range
$15-$19
Price range past year
Annual Return
+1.9%
Cumulative gain past year
| Period | HBAN Return | S&P 500 |
|---|---|---|
| 1m | -3.5% | +1.4% |
| 3m | +3.7% | +3.9% |
| 6m | +0.6% | +6.3% |
| 1y | +1.9% | +16.0% |
| ytd | -1.8% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HBAN Fundamental Analysis
Revenue has been growing strongly, with Q1 2026 revenue of $3.768 billion up 26.3% year-over-year, accelerating from the 2.0% growth in Q2 2025. The multi-quarter trend shows revenue rising from $2.967 billion in Q2 2024 to $3.768 billion in Q1 2026, driven by higher net interest income and fee income. Net income in Q1 2026 was $523 million, up from $527 million in Q1 2025, with EPS of $0.26. Gross margin has improved to 64.1% in Q1 2026 from 57.4% in Q3 2024, indicating better cost management and higher net interest margins. The net margin of 13.9% in Q1 2026 is slightly below the 17.7% in Q1 2025, but the operating margin of 17.0% remains healthy. The balance sheet shows a debt-to-equity ratio of 0.76, which is moderate for a regional bank. Free cash flow (TTM) is $2.206 billion, providing ample coverage for dividends and investments. ROE of 9.1% is reasonable but below some peers, while the current ratio of 0.19 is low, typical for banks due to their business model. The company generated $524 million in operating cash flow in Q1 2026, sufficient to cover capital expenditures of $124 million and dividends of $291 million.
Quarterly Revenue
$3.8B
2026-03
Revenue YoY Growth
+26.3%
YoY Comparison
Gross Margin
64.1%
Latest Quarter
Free Cash Flow
$2.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HBAN Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 12.3x, while the forward P/E is 9.2x, implying the market expects earnings growth. The gap between trailing and forward P/E suggests a 25% expected earnings increase, which aligns with analyst estimates of $1.73 EPS for the current year. Compared to the industry average P/E of 15.0x (estimated from sector data), HBAN trades at a discount of about 18%, which may be justified by its lower ROE and growth profile relative to larger peers. Historically, the stock's trailing P/E has ranged from 7.0x to 21.2x over the past three years. The current 12.3x is near the lower end of that range, suggesting the stock is not overvalued relative to its own history. The P/B ratio of 1.05x is also below the historical average of around 1.1x, indicating potential value if the bank can improve its returns.
PE
12.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Huntington's debt-to-equity ratio of 0.76 is moderate, but the current ratio of 0.19 is typical for banks and not a liquidity concern. The net margin decline from 17.7% in Q1 2025 to 13.9% in Q1 2026 is a key risk, as it suggests rising costs or credit provisions that could pressure earnings. Free cash flow of $2.206 billion TTM is strong, but the payout ratio of 46% leaves limited room for dividend increases if earnings falter. Revenue concentration in the Midwest exposes the bank to regional economic downturns, though diversification across consumer and commercial segments mitigates this somewhat.
Market & Competitive Risks: The stock's beta of 0.95 indicates slightly less volatility than the market, but its 1-year underperformance (-12.1% relative strength) suggests it is out of favor. Valuation compression risk exists if the market re-rates regional banks lower due to economic uncertainty; the trailing P/E of 12.3x is already below the industry average of 15.0x, but could fall further. Competitive pressures from larger national banks and fintechs could erode market share in lending and deposits. The recent Jefferies downgrade highlights shifting analyst sentiment, though most analysts remain bullish.
Worst-Case Scenario: A severe economic recession could lead to rising loan defaults, compressing net interest margins and forcing higher provisions. In such a scenario, the stock could fall to its 52-week low of $14.89, representing a 14.2% decline from the current price of $17.36. If earnings disappoint and the P/E contracts to 10x (near its 3-year low of 7.0x), the stock could drop to around $13.00, a 25% loss. The maximum drawdown over the past year was -22.06%, so a repeat of that magnitude would bring the stock to approximately $13.53.